Mayo Center for Cell Signaling in Gastroenterology
梅奥胃肠病学细胞信号转导中心
基本信息
- 批准号:8699451
- 负责人:
- 金额:$ 119.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-01 至 2019-08-31
- 项目状态:已结题
- 来源:
- 关键词:Biological ModelsCellsClinicClinicalClinical TrialsDiagnosisDigestive System DisordersDirect CostsDisciplineEducational CurriculumEducational workshopEquipmentFacultyFosteringFundingGastroenterologyGastrointestinal DiseasesGene Expression RegulationGeneticGenetic ModelsGoalsGrantGrowthHealthInterdisciplinary StudyIon ChannelLeadMembraneMethodologyMicroscopicMicroscopyMonitorNational Institute of Diabetes and Digestive and Kidney DiseasesOnline SystemsOpticsPathway interactionsPatientsPeer ReviewPreventionProcessPublic HealthReagentResearchResearch InfrastructureResearch PersonnelResearch SupportScientistSignal PathwaySignal TransductionTechnologyTherapeuticTranslationsVisitbaseclinical carecostgastrointestinalgenetic technologyhealth care service utilizationhuman diseaseimprovedmembermultidisciplinarypatient orientedpractical applicationprogramspublic health relevancereceptorsymposiumtherapeutic target
项目摘要
DESCRIPTION, OVERALL (provided by applicant): The goal of the Mayo Clinic Center for Cell Signaling in Gastroenterology (C-SiG) is to connect discovery, translational, and patient-oriented investigators to enhance understanding and therapeutically exploit signaling pathways in gastrointestinal cells to improve the health of patients with digestive diseases. The Research Base consists of 59 scientists and $23 million (direct costs, 70% growth) in digestive disease related funding. C-SiG members are organized into three Mechanistic Research Themes: 1) Ion channels/membrane receptors; ii) Signal transduction; and, iii) Genetics and gene regulation. Our CENTRAL HYPOTHESIS is that advances in clinical care of patients with digestive diseases requires a facilitative infrastructure supporting meaningful interactions among multidisciplinary scientists investigating cellular mechanisms, pathways and therapeutic targets to enhance rapid translation of basic discoveries into clinical trials. C-SiG's OVERALL SPECIFIC AIMS are to: i) Foster multidisciplinary research by expanding technical and collaborative capabilities of established Gl scientists and attracting investigators from other disciplines; li) Develop and implement a robust Scientific Enrichment Program that includes seminars, workshops, symposia, a visiting faculty program, minisabbatical, and Web-based curricula; iii) Offer specialized equipment, technologies, methodologies, reagents, and expertise to assist C-SiG members through the C-SiG Cores, including: a) State-of-the-art microscopic technology and consultative expertise (Optical Microscopy Core); b) Accelerated and expanded biospecimen acquisition, processing, and annotation (Clinical Core); c) Emerging genetic technologies and model systems (Genetics and Model Systems Core); iv) Identify and nurture new Gl investigators via a peer-reviewed Pilot and Feasibility Program; v) Promote synergistic interactions between C-SiG members and other Gl investigators at Mayo and at other Gl centers to facilitate clinical trials resulting from the identification of cellular therapeutic tarets; vi) Share technologies with other NIDDK centers at Mayo (e.g., PKD Center) and existing Digestive Disease Research Core Centers, especially in the Midwest (i.e. Midwest DDRCC Alliance).
描述,总体(由申请人提供):胃肠病学(C-SIG)中蛋黄酱诊所信号转导的目标是连接发现,转化和以患者为导向的研究者,以增强理解和治疗利用胃肠道细胞中的信号通路,以改善患有消化性疾病患者的健康状况。研究基础包括59位科学家和2300万美元(直接成本,增长70%)与消化疾病有关的资金组成。 C-SIG成员分为三个机械研究主题:1)离子通道/膜受体; ii)信号转导; iii)遗传学和基因调节。我们的中心假设是,消化疾病患者的临床护理进展需要促进基础设施,以支持多学科科学家之间有意义的相互作用,研究了细胞机制,途径和治疗靶标,以将基本发现的快速转化为临床试验。 C-SIG的总体具体目的是:i)通过扩大已建立GL科学家的技术和协作能力来培养多学科研究,并吸引其他学科的研究人员; li)制定并实施一个强大的科学丰富计划,其中包括研讨会,研讨会,研讨会,访问教师计划,MiniSablation和基于Web的课程; iii)提供专业设备,技术,方法,试剂和专业知识,以通过C-SIG核心为C-SIG成员提供帮助,包括:a)最先进的显微镜技术和咨询专业知识(光学显微镜核心); b)加速和扩大生物素的获取,加工和注释(临床核心); c)新兴的遗传技术和模型系统(遗传学和模型系统核心); iv)通过同行评审的飞行员和可行性计划来识别和培养新的GL研究人员; v)促进梅奥和其他GL中心的C-SIG成员与其他GL研究者之间的协同相互作用,以促进鉴定细胞治疗焦油的临床试验; vi)与Mayo(例如PKD中心)和现有的消化疾病研究核心中心的其他NIDDK中心共享技术,尤其是在中西部(即中西部DDRCC联盟)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nicholas F. LaRusso其他文献
Abnormalities of Chemical Tests for Copper Metabolism in Chronic Active Liver Disease: Differentiation from Wilson's Disease
- DOI:
10.1016/s0016-5085(76)80249-1 - 发表时间:
1976-05-01 - 期刊:
- 影响因子:
- 作者:
Nicholas F. LaRusso;William H.J. Summerskill;John T. McCall - 通讯作者:
John T. McCall
The AGA Institute: A Professional Society With a Social Conscience
- DOI:
10.1053/j.gastro.2008.10.019 - 发表时间:
2008-12-01 - 期刊:
- 影响因子:
- 作者:
Nicholas F. LaRusso - 通讯作者:
Nicholas F. LaRusso
Nitric oxide (NO) inhibits apoptosis in cholangiocarcinoma cells by blocking caspase 9 activation
- DOI:
10.1016/s0016-5085(00)85990-9 - 发表时间:
2000-04-01 - 期刊:
- 影响因子:
- 作者:
Natalie J. Torok;Timothy J. Kottke;Scott H. Kaufmann;Nicholas F. LaRusso;Gregory J. Gores;Mayo Clin - 通讯作者:
Mayo Clin
1103 - Fluorescence-Activated Cell Sorting of Enteroendocrine Cells in Humans: Technique Validation by Mucosal Endoscopic Biopsies and Novel Progression to <em>Ex-Vivo</em> Studies
- DOI:
10.1016/s0016-5085(18)31118-1 - 发表时间:
2018-05-01 - 期刊:
- 影响因子:
- 作者:
Alison N. Bonis;Geoffrey Roberts;Gerardo Calderon;Julie Woodrum;Jeffrey Salisbury;Frank Reimann;Michael Camilleri;Nicholas F. LaRusso;Fiona Gribble;Andres Acosta - 通讯作者:
Andres Acosta
Bidirectional water transport across biliary epithelia
- DOI:
10.1016/s0016-5085(00)85860-6 - 发表时间:
2000-04-01 - 期刊:
- 影响因子:
- 作者:
Anatoly I. Masyuk;Michael J. Burke;Ai-Yu Gong;Nicholas F. LaRusso - 通讯作者:
Nicholas F. LaRusso
Nicholas F. LaRusso的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nicholas F. LaRusso', 18)}}的其他基金
Midwest DDRCC Alliance Conference (Hosted by the Mayo Clinic DDRCC)
中西部DDRCC联盟会议(由梅奥诊所DDRCC主办)
- 批准号:
10675868 - 财政年份:2023
- 资助金额:
$ 119.25万 - 项目类别:
The Development of TGR5 Antagonists for the Treatment of Cholangiopathies
用于治疗胆管病的 TGR5 拮抗剂的开发
- 批准号:
10201582 - 财政年份:2019
- 资助金额:
$ 119.25万 - 项目类别:
The Development of TGR5 Antagonists for the Treatment of Cholangiopathies
用于治疗胆管病的 TGR5 拮抗剂的开发
- 批准号:
10018484 - 财政年份:2019
- 资助金额:
$ 119.25万 - 项目类别:
The Development of TGR5 Antagonists for the Treatment of Cholangiopathies
用于治疗胆管病的 TGR5 拮抗剂的开发
- 批准号:
10431962 - 财政年份:2019
- 资助金额:
$ 119.25万 - 项目类别:
Mayo Center for Cell Signaling in Gastroenterology
梅奥胃肠病学细胞信号转导中心
- 批准号:
7908858 - 财政年份:2009
- 资助金额:
$ 119.25万 - 项目类别:
Mayo Center for Cell Signaling in Gastroenterology
梅奥胃肠病学细胞信号转导中心
- 批准号:
10630250 - 财政年份:2009
- 资助金额:
$ 119.25万 - 项目类别:
Mayo Center for Cell Signaling in Gastroenterology
梅奥胃肠病学细胞信号转导中心
- 批准号:
10438737 - 财政年份:2009
- 资助金额:
$ 119.25万 - 项目类别:
Mayo Center for Cell Signaling in Gastroenterology
梅奥胃肠病学细胞信号转导中心
- 批准号:
8309305 - 财政年份:2009
- 资助金额:
$ 119.25万 - 项目类别:
Mayo Center for Cell Signaling in Gastroenterology
梅奥胃肠病学细胞信号转导中心
- 批准号:
8903714 - 财政年份:2009
- 资助金额:
$ 119.25万 - 项目类别:
相似国自然基金
Galectin-3调控PD-L1在原发性肝细胞癌免疫治疗和预后中的作用及机制
- 批准号:82304216
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FOXO3 m6A甲基化修饰诱导滋养细胞衰老效应在补肾法治疗自然流产中的机制研究
- 批准号:82305286
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
神经母细胞瘤EDF1促进神经节苷脂贮积诱导CD8+T细胞耗竭的机制研究
- 批准号:82373421
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
肝细胞CREG1抑制其富含miR-34的外泌体分泌并减少巨噬细胞的活化,进而延缓肝纤维化的进展
- 批准号:82300713
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
化学小分子激活YAP诱导染色质可塑性促进心脏祖细胞重编程的表观遗传机制研究
- 批准号:82304478
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Genetics of Extreme Phenotypes of OSA and Associated Upper Airway Anatomy
OSA 极端表型的遗传学及相关上呼吸道解剖学
- 批准号:
10555809 - 财政年份:2023
- 资助金额:
$ 119.25万 - 项目类别:
Bottom-up, high-throughput prototyping of extracellular vesicle mimetics using cell-free synthetic biology
使用无细胞合成生物学对细胞外囊泡模拟物进行自下而上的高通量原型设计
- 批准号:
10638114 - 财政年份:2023
- 资助金额:
$ 119.25万 - 项目类别:
Potential of tissue kallikreins as therapeutic targets for neuropsychiatric lupus
组织激肽释放酶作为神经精神狼疮治疗靶点的潜力
- 批准号:
10667764 - 财政年份:2023
- 资助金额:
$ 119.25万 - 项目类别:
Project 3: Therapeutic Gene Editing for Huntington's Disease
项目3:亨廷顿病的治疗性基因编辑
- 批准号:
10668769 - 财政年份:2023
- 资助金额:
$ 119.25万 - 项目类别:
Establishing patient-derived iPSCs as a platform for discovery research in NAFLD
建立源自患者的 iPSC 作为 NAFLD 发现研究的平台
- 批准号:
10647450 - 财政年份:2023
- 资助金额:
$ 119.25万 - 项目类别: